http://www.metabolomicdiagnostics.com/

Metabolomic Diagnostics, Hoffmann Park, Inchera, Cork (2025)

10/03/2024

As we celebrate Mother's Day, it's a beautiful moment to reflect on the incredible voyage of expectancy. Whether you're a first-time mammy or expanding your family, each pregnancy weaves a unique tapestry of emotions deserving our heartfelt recognition. 🌷 Let's cherish the magic of the extraordinary experience of nurturing life. Happy Mother's Day to all the amazing mammys-to-be! 🤰🎉 hashtag hashtag hashtag

11/01/2024

What else would patients have liked their doctors to tell them during their experience? The teams and partnered to collect patients’ feedback about their experiences and how we . Visual storyteller Ashanti Gardner then beautifully captured these preeclampsia patient voices – and the result is a powerful illustration of real life experiences. Read more about this illustrative journey and access these images at www.preeclampsia.org/MakePreeclampsiaHistory

10/01/2024

What else would patients have liked their doctors to tell them during their experience? The teams and partnered to collect patients’ feedback about their experiences and how we . Visual storyteller Ashanti Gardner then beautifully captured these preeclampsia patient voices – and the result is a powerful illustration of real life experiences. Read more about this illustrative journey and access these images at www.preeclampsia.org/MakePreeclampsiaHistory

18/12/2023

At Metabolomic Diagnostics, we are immensely grateful for our incredible journey in 2023, and we couldn't have done it without the unwavering support of our exceptional stakeholders - our brilliant investors, inspirational patients, dedicated employees, and visionary partners.

Their trust and belief in our mission have fueled our stride. Our partnerships and their unwavering commitment have driven our relentless pursuit of innovation, propelling us toward groundbreaking discoveries and advancements.

This year has been a testament to resilience, determination, and the collaborative spirit that defines our community. Despite the challenges, our partnerships have been the cornerstone of our success, inspiring us to push boundaries, defy limitations, and forge new pathways to pursue scientific excellence.

As we enter 2024, the horizon is ablaze with promise and potential. We anticipate a year of groundbreaking discoveries, transformative advancements, and an even more substantial commitment to enhancing lives through technology and science.

We extend our warmest wishes for a joyous holiday season filled with love, peace, and cherished moments with your loved ones. We embrace the new year enthusiastically and determined, knowing our efforts will continue shaping a brighter, healthier future for all pregnant people.

13/12/2023

Addressing bias in healthcare is crucial for equitable treatment, especially for pregnant Black women. Roni Caryn Rabin's series of articles for The New York Times highlights the devastating impact of unconscious bias on maternal health.

Studies reveal disturbing disparities in care. Black women face dismissive attitudes, leading to deadly consequences for both mothers and babies. Instances of doctors dominating conversations with Black patients and expressing scepticism towards reported symptoms have been documented.

This systemic bias translates into worse pregnancy outcomes for Black women, even compared to white women with similar complications. The medical community acknowledges these biases and is implementing measures like anti-bias training and case reviews to address these issues.

Experts stress that many healthcare professionals don't consciously harbour biases, yet these unconscious biases influence their care. Dr. Cristina M. Gonzalez rightly points out that unconscious biases often govern decisions, impacting patient care significantly.

The heartbreaking experiences shared by individuals shed light on the real, devastating consequences of biased healthcare. Instances where medical staff disregarded critical symptoms, leading to stillbirths and maternal deaths, demand immediate attention and reform in healthcare practices.

This critical issue emphasizes the urgent need for change in medical practices, ensuring equitable, empathetic, and attentive care for all patients. We are working collectively to address unconscious bias in healthcare and strive for equitable treatment for every individual, regardless of race or background.

[Full article: Roni Caryn Rabin for The New York Times - Dec. 12, 2023. https://www.nytimes.com/2023/12/12/health/pregnant-black-women-bias.html?unlocked_article_code=1.Fk0.-tEb.4KTvEsHfb3Zu&hpgrp=ar-abar&smid=url-share]

04/12/2023

The Impact of Reliable Automation in Translational Metabolomics

https://www.linkedin.com/events/theimpactofreliableautomationin7132650999722201088/

Join us for a game-changing webinar featuring our CEO, Dr Robin Tuytten, exploring the power of automated liquid handling in metabolomic diagnostics. Discover how LC-MS/MS sample preparation identifies 30+ metabolites predicting adverse pregnancy outcomes like pre-eclampsia. Uncover the impact of precise liquid handling in and the BRAVO robot's role in Metabolomic Diagnostics.

Take advantage of this opportunity to explore the fast, multiplexed determinations reshaping the future of healthcare!

Elizabeth Leslie Catherine Kate Jeevagayathri Ciara

01/12/2023

The Impact of Reliable Automation in Translational Metabolomics

Join us for a game-changing webinar featuring our CEO, Dr Robin Tuytten, exploring the power of automated liquid handling in metabolomic diagnostics. Discover how LC-MS/MS sample preparation identifies 30+ metabolites predicting adverse pregnancy outcomes like pre-eclampsia. Uncover the impact of precise liquid handling in and the BRAVO robot's role in Metabolomic Diagnostics.

Take advantage of this opportunity to explore the fast, multiplexed determinations reshaping the future of healthcare!

https://www.linkedin.com/feed/update/urn:li:activity:7132651003643879424

30/11/2023

It is part of our mission to highlight interesting scientific studies that bring new perspectives into women's health, especially concerning pregnancy.

Are women who had preeclampsia at higher risk of venous thromboembolism (VTE)?

Enlightening findings from a recent cohort study of 522,545 primiparous women published in JAMA show that preeclampsia, which is a pregnancy-induced hypertensive disorder, emerged as a factor linked to increased VTE risk during pregnancy, the puerperium, and even after that period. This association stood firm even after adjusting for potential confounders.

This highlights the need for increased awareness and tailored care for women with a history of preeclampsia to prevent VTE, a leading cause of morbidity and mortality, throughout their lives.

This study offers a compelling angle for those fascinated by the intersection of pregnancy complications and long-term health outcomes.

28/11/2023

At Metabolomic Diagnostics, we are devoted to sharing groundbreaking studies in women's health. Cardiovascular issues stand as the leading cause of mortality among women, making proactive measures pivotal during pivotal moments like pregnancy.

This recent study (https://www.ahajournals.org/doi/epdf/10.1161/HYPERTENSIONAHA.123.21573), conducted by leading experts, focused on developing a predictive model to identify women at heightened risk for chronic hypertension (CH) based on data collected during their pregnancy. They delved into a cohort of 26,511 women across two consecutive pregnancies, aiming to utilize this critical period to implement effective prevention strategies.

The findings are remarkable. Early pregnancy maternal characteristics, blood pressure, and development of preeclampsia or GH (gestational hypertension) identify three-fourths of women at risk for future CH.

Here are some key highlights:

- Identified Predictors: Factors such as maternal age, weight, blood pressure, ethnicity (Black and South Asian), family history of preeclampsia, parity, and development of preeclampsia or GH emerged as predictors for future CH.

- Preventative Strategy: The model successfully pinpointed three-fourths of women at risk for future CH, showcasing the potential to revolutionize preventive healthcare strategies globally.

- Impactful Results: At a screen-positive rate of 10%, our model incorporating maternal characteristics, early pregnancy blood pressure, and preeclampsia/GH detection achieved an impressive 73.5% detection rate for future CH, offering a promising pathway for early intervention and personalized care.

This research isn't just about data; it's about empowering women with proactive health measures. By identifying risk factors early on, healthcare providers worldwide can implement targeted interventions.

We're committed to leveraging scientific advancements to improve healthcare outcomes. Like and share!

15/11/2023

Did you know that November 19th is recognized as International Men's Day? It's a day dedicated to raising awareness about various challenges faced by men (including parental alienation, abuse, homelessness, su***de, and violence) and focuses on men’s health and wellbeing.

We are celebrating the men in our lives and working towards a healthier, more supportive world for everyone!

📆 Save the Date: November 16th, 2023
This Thursday, the Health and Safety Executive (HSE) is marking the occasion with a webinar featuring men who have become advocates for men's health and wellbeing. Don't miss out! https://lnkd.in/eH_x7-kM

📆 Event in Cork - Save the Date: November 28th, 2023
Nurturing Mental Wellness in the Workplace
The Psyched team is hosting an insightful event in Cork at the end of the month. Explore the theme of nurturing mental wellness in the workplace with speakers like Biddy O'Neill, Dr. Jane Bourke, and Dr. Nic Marks. Dr. Nic, a creator of The 5 Ways to Wellbeing, will share his expertise. https://lnkd.in/eWP_ji43

📆 Recent Research from Cork
Check out the Lancet-published paper on 'Work-related causes of mental health conditions and interventions for their improvement in workplaces.' Dr. Birgit Greiner and Professor Ella Arensman, from UCC School of Public Health and the National Su***de Research Foundation, co-authored this insightful article with academics from around the globe. Read Dr. Greiner's findings https://lnkd.in/esPqFCcR

Let's use this International Men's Day to foster understanding, support, and positive change. Together, we can create a world where everyone's mental health and wellbeing are top priorities. 💙 .

14/11/2023

President of the United States Joe Biden has signed a presidential memorandum to establish the first-ever The White House Initiative on Women's Health Research.

The initiative, championed by First Lady Dr Jill Biden, Jennifer Klein, Dr Carolyn M. Mazure, and Maria Shriver, aims to address the historical underrepresentation of women in health research and the insufficient funding allocated to such research.

The President highlights the need for all government agencies related to health, including NIH, HHS, the VA, and the Defense Department, to collaborate and provide a report within 45 days on their current efforts and suggestions for improving women's health. Progress reports will be made available to the President at least twice yearly.

Maria Shriver's leadership and Carolyn's commitment to leading the initiative were acknowledged at the signing ceremony. First Lady Dr Jill Biden expressed gratitude for the President's responsiveness to concerns raised, emphasizing that women deserve better and that this initiative will bring about positive change. They acknowledged the imbalance in women's health research funding and expressed determination to address the issue.

The functions of the memorandum include assessing the federal research landscape, setting priorities, improving coordination among agencies, developing policy recommendations, addressing health disparities, promoting public-private partnerships, and engaging the scientific community. The document also underscores the potential societal gains from increased women's health research investments. Furthermore, it directs the Secretary of Health and Human Services to publish the memorandum in the Federal Register.

🔗: https://www.whitehouse.gov/

08/11/2023

Our fantastic team is composed of highly specialised individuals wholly committed to advancing our products - they are based all over Europe and come from 4 different continents.
Their specialism varies from clinical experience to deep tech understanding of analytical chemistry, encompassing quality, manufacturing and biostatistics knowledge.

In the words of our CEO, Robin Tuytten: ''...In the past decade, many people from across the globe have committed some of their passion to our mission of making pregnancies safer for all women, their/our children, their/our families, and their/our communities. Whether colleagues joined us only for a few weeks as part of an internship or dedicated years of their professional lives to help us make an impact, each and every one of them made us better. On behalf of the current team – we thank you All! To the current team: Metabolomic Diagnostics, SQU4RE.com, Tession Ltd, Simon Smith, mdeg - Medical Device Engineering Group - Stellar Performance! Very Proud, Very Privileged, and Very Thankful (not to mention the fun we have as well...)''.

Metabolomic Diagnostics

10/03/2024

11/01/2024

10/01/2024

18/12/2023

13/12/2023

04/12/2023

01/12/2023

30/11/2023

28/11/2023

15/11/2023

14/11/2023

08/11/2023

Address

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share